Less than a third of ED visits for acute sickle cell disease pain were guideline-adherent for the timely administration of ...
Motixafortide alone and in combination with natalizumab can support the collection of the large number of stem cells required ...
Presented new data in non-human primates (NHP) for sickle cell disease (SCD), where RNA Gene Writer achieved approximately 40% and 60% of ...
Adding erythropoietin to hydroxyurea treatment could significantly improve quality of life for patients with sickle cell ...
Cellarity, a clinical-stage biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced the presentation of new preclinical data on ...
Key Highlights Motixafortide effectively mobilized sufficient hematopoietic stem cells (HSCs) in patients with sickle cell disease enabling accelerated access to gene therapies 90% (9 of 10) of ...
Preliminary results from two trials of the gene therapy exagamglogene autotemcel (exa-cel) suggest the therapy offers an ...
From 2008 to 2023, there has been a significant decrease in cystic fibrosis mortality rates and a significant rise in sickle ...
Roseland Community Hospital on Monday celebrated the opening of a new sickle cell treatment clinic. The ribbon was cut at 9 a ...
News-Medical.Net on MSN
New evidence shows hematopoietic cell transplantation offers durable relief for sickle cell disease
Patients who underwent hematopoietic cell transplantation for sickle cell disease saw high rates of survival without disease ...
Fulcrum Therapeutics stock surges on Monday after releasing positive results from Phase 1b trial of pociredir in sickle cell ...
As a parent with a child who has sickle cell disease, you are always on high alert. The “what if” stays with me, as it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results